CanCOLD, Canada

Registration Status: Pending

Objective: CanCOLD (Canadian Cohort of Obstructive Lung Disease) is a prospective multi-center cohort study conducted across Canada, dedicated to increase our understanding on the Chronic Obstructive Pulmonary Disease (COPD) and related co-morbidities, to improve its management and to reduce its burden. This first population based long-term COPD cohort study in Canada is set to end in 2023.

Registered Biobank Name CanCOLD
Biobank Leader Wan Tan
Country Canada
Email for biobank inquiries
Principal Investigator Wan Tan
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.
Biospecimen Collected: